Weinstein Imaging Associates Introduces 'Breast-Specific Gamma Imaging' to Region

-- New testing procedure helps diagnose breast cancer - earlier and at a

cellular level

-- Evaluates questionable findings on mammography or ultrasound

-- Serves as a problem-solving tool for challenging cases, complements

mammography



24 Jul, 2007, 01:00 ET from Weinstein Imaging Associates

    PITTSBURGH, July 24 /PRNewswire/ -- Weinstein Imaging Associates, a
 leading ultrasound and breast imaging facility in Western Pennsylvania, is
 introducing to the region Breast-Specific Gamma Imaging (BSGI), an
 innovative technology and advanced diagnostic test that helps to detect
 breast cancers and evaluate questionable findings on mammography or
 ultrasound. Preliminary results and responses from Weinstein Imaging
 patients have been favorable.
     According to the American Cancer Society, more than 8,800 cases of
 breast cancer will be diagnosed in Pennsylvania this year. Approximately 15
 percent of these cancers will not be detectable by mammography, usually
 because of masking by dense breast tissue.
     Performed with the Dilon 6800 high-resolution Gamma Camera, BSGI is an
 effective problem-solving test and diagnostic tool, particularly when dense
 breast tissue is present, and it is considered an ideal complement to
 mammography when additional assessment is needed.
     Mammography primarily measures differences in tissue density, but
 because dense tissue and cancers often have the same color and structure on
 a mammogram, cancers may blend in with the normal surrounding tissue and be
 difficult to see. BSGI measures differences at the cellular level and is
 not affected by tissue density. It is also useful for patients who have
 scar tissue, breast implants or a palpable lump when a mammogram and
 ultrasound are normal.
     The new molecular imaging technique has a high sensitivity for the
 detection of small breast cancers. In addition, it has infrequent false-
 positive results, which means that many surgical biopsies for benign
 conditions can be avoided.
     When patients have a BSGI test, they receive a small amount of a
 tracing agent that is absorbed by all cells in their body. Because
 cancerous cells have higher metabolic activity, they absorb more of it and
 thereby show up as "hot spots" on the gamma camera pictures. BSGI takes
 about 45-to-60 minutes to perform. Since tight compression of the breast is
 not necessary and patients are seated throughout the procedure, they
 generally find the exam to be comfortable. Although it is a relatively new
 test, most insurance companies already pay for BSGI.
     "We are dedicated to providing patients with the most advanced
 technology in breast imaging and our capability is greatly enhanced by
 BSGI," said Thomas S. Chang, M.D., FACR, Weinstein Imaging Associates.
 "Breast cancer is highly curable when found and treated in its earliest
 stages. BSGI can help us find early cancers, while also allowing us to
 avoid many unnecessary surgical biopsies."
     Since implementing BSGI in May 2007, Weinstein Imaging Associates has
 used the new technology in 26 patient cases. Cancer was diagnosed in two of
 these cases.
     Patient Case #1 Ruth B. of Pittsburgh: Ruth's recent mammograms were
 difficult to read because of her past surgery and radiation that obscured
 views. She followed Weinstein Imaging's recommendation to have supplemental
 BSGI testing, which provided conclusive data and a "sigh of relief that
 there were no cancerous cells in hidden areas." Ruth praised the new
 technology and quality of care, along with the way it allows "experts to
 establish a baseline to compare to future mammograms and sonograms ..."
 Testimonial: http://www.weinsteinimaging.com/feedback.html
     Patient Case #2 Resident of Pittsburgh: This patient had painful
 breasts. A recent mammogram showed no definitive signs of cancer -- just
 questionable areas that made it difficult to diagnose her condition
 conclusively. Her regular doctor felt the risk of cancer was low and no
 supplemental testing was necessary, but the patient was experiencing high
 levels of anxiety and wanted to have BSGI to obtain more information and
 increase her confidence level. She proceeded with testing, and BSGI in fact
 confirmed the presence of cancer, "lighting up" hot spots that were not
 detectable on her mammogram. Through BSGI testing, this patient's cancer
 was discovered earlier than previously possible, allowing for more timely
 diagnosis and medical care.
     (Note: National-level case histories available at
 http://www.estetacommunications.com/WIA/WIA.htm)
     Introduction of BSGI to the region is one of several recent Weinstein
 Imaging developments that are advancing breast health and quality of care.
 In recent years, the practice also began offering breast MRI and MRI-guided
 breast biopsies (through an affiliation with West Mifflin Imaging); digital
 mammography, which is effective in detecting cancer in dense breast tissue;
 3D ultrasound; measurement and documentation of fetal nuchal translucency
 for early diagnosis of chromosomal abnormalities; and filmless presentation
 of expectant-mother-and-child images on DVD/CDs.
     Expanding its community-education efforts, Weinstein Imaging Associates
 is planning to meet in upcoming months with numerous organizations and
 civic groups to inform members of new imaging technologies "beyond
 mammography" and emphasize the importance of early diagnosis.
     Located in Pittsburgh, PA, since 1980, Weinstein Imaging Associates is
 the premier ultrasound and mammography facility in Western Pennsylvania and
 the Greater Pittsburgh tri-state region. Physicians are recognized
 radiologists who have been selected to evaluate images from across the
 country as part of national quality assurance programs in mammography and
 sonography. Technologists and staff are also among the best in their
 specialties. Offices are in the Shadyside, South Hills and North Hills
 areas of Pittsburgh. weinsteinimaging.com
     CONTACTS: Michele Rothert,
               Esteta Communications
               412-322-0281
               mr@estetacommunications.com
 
               Mary Lou Bradley
               Weinstein Imaging Associates
               412-441-1161
               bradley@weinsteinimaging.com
     EDITORIAL NOTE: PHOTOS, BIOS, LOGOS, VIDEO, CASE HISTORIES AVAILABLE
 at: http://www.estetacommunications.com/WIA/WIA.htm
 
 

SOURCE Weinstein Imaging Associates
    PITTSBURGH, July 24 /PRNewswire/ -- Weinstein Imaging Associates, a
 leading ultrasound and breast imaging facility in Western Pennsylvania, is
 introducing to the region Breast-Specific Gamma Imaging (BSGI), an
 innovative technology and advanced diagnostic test that helps to detect
 breast cancers and evaluate questionable findings on mammography or
 ultrasound. Preliminary results and responses from Weinstein Imaging
 patients have been favorable.
     According to the American Cancer Society, more than 8,800 cases of
 breast cancer will be diagnosed in Pennsylvania this year. Approximately 15
 percent of these cancers will not be detectable by mammography, usually
 because of masking by dense breast tissue.
     Performed with the Dilon 6800 high-resolution Gamma Camera, BSGI is an
 effective problem-solving test and diagnostic tool, particularly when dense
 breast tissue is present, and it is considered an ideal complement to
 mammography when additional assessment is needed.
     Mammography primarily measures differences in tissue density, but
 because dense tissue and cancers often have the same color and structure on
 a mammogram, cancers may blend in with the normal surrounding tissue and be
 difficult to see. BSGI measures differences at the cellular level and is
 not affected by tissue density. It is also useful for patients who have
 scar tissue, breast implants or a palpable lump when a mammogram and
 ultrasound are normal.
     The new molecular imaging technique has a high sensitivity for the
 detection of small breast cancers. In addition, it has infrequent false-
 positive results, which means that many surgical biopsies for benign
 conditions can be avoided.
     When patients have a BSGI test, they receive a small amount of a
 tracing agent that is absorbed by all cells in their body. Because
 cancerous cells have higher metabolic activity, they absorb more of it and
 thereby show up as "hot spots" on the gamma camera pictures. BSGI takes
 about 45-to-60 minutes to perform. Since tight compression of the breast is
 not necessary and patients are seated throughout the procedure, they
 generally find the exam to be comfortable. Although it is a relatively new
 test, most insurance companies already pay for BSGI.
     "We are dedicated to providing patients with the most advanced
 technology in breast imaging and our capability is greatly enhanced by
 BSGI," said Thomas S. Chang, M.D., FACR, Weinstein Imaging Associates.
 "Breast cancer is highly curable when found and treated in its earliest
 stages. BSGI can help us find early cancers, while also allowing us to
 avoid many unnecessary surgical biopsies."
     Since implementing BSGI in May 2007, Weinstein Imaging Associates has
 used the new technology in 26 patient cases. Cancer was diagnosed in two of
 these cases.
     Patient Case #1 Ruth B. of Pittsburgh: Ruth's recent mammograms were
 difficult to read because of her past surgery and radiation that obscured
 views. She followed Weinstein Imaging's recommendation to have supplemental
 BSGI testing, which provided conclusive data and a "sigh of relief that
 there were no cancerous cells in hidden areas." Ruth praised the new
 technology and quality of care, along with the way it allows "experts to
 establish a baseline to compare to future mammograms and sonograms ..."
 Testimonial: http://www.weinsteinimaging.com/feedback.html
     Patient Case #2 Resident of Pittsburgh: This patient had painful
 breasts. A recent mammogram showed no definitive signs of cancer -- just
 questionable areas that made it difficult to diagnose her condition
 conclusively. Her regular doctor felt the risk of cancer was low and no
 supplemental testing was necessary, but the patient was experiencing high
 levels of anxiety and wanted to have BSGI to obtain more information and
 increase her confidence level. She proceeded with testing, and BSGI in fact
 confirmed the presence of cancer, "lighting up" hot spots that were not
 detectable on her mammogram. Through BSGI testing, this patient's cancer
 was discovered earlier than previously possible, allowing for more timely
 diagnosis and medical care.
     (Note: National-level case histories available at
 http://www.estetacommunications.com/WIA/WIA.htm)
     Introduction of BSGI to the region is one of several recent Weinstein
 Imaging developments that are advancing breast health and quality of care.
 In recent years, the practice also began offering breast MRI and MRI-guided
 breast biopsies (through an affiliation with West Mifflin Imaging); digital
 mammography, which is effective in detecting cancer in dense breast tissue;
 3D ultrasound; measurement and documentation of fetal nuchal translucency
 for early diagnosis of chromosomal abnormalities; and filmless presentation
 of expectant-mother-and-child images on DVD/CDs.
     Expanding its community-education efforts, Weinstein Imaging Associates
 is planning to meet in upcoming months with numerous organizations and
 civic groups to inform members of new imaging technologies "beyond
 mammography" and emphasize the importance of early diagnosis.
     Located in Pittsburgh, PA, since 1980, Weinstein Imaging Associates is
 the premier ultrasound and mammography facility in Western Pennsylvania and
 the Greater Pittsburgh tri-state region. Physicians are recognized
 radiologists who have been selected to evaluate images from across the
 country as part of national quality assurance programs in mammography and
 sonography. Technologists and staff are also among the best in their
 specialties. Offices are in the Shadyside, South Hills and North Hills
 areas of Pittsburgh. weinsteinimaging.com
     CONTACTS: Michele Rothert,
               Esteta Communications
               412-322-0281
               mr@estetacommunications.com
 
               Mary Lou Bradley
               Weinstein Imaging Associates
               412-441-1161
               bradley@weinsteinimaging.com
     EDITORIAL NOTE: PHOTOS, BIOS, LOGOS, VIDEO, CASE HISTORIES AVAILABLE
 at: http://www.estetacommunications.com/WIA/WIA.htm
 
 SOURCE Weinstein Imaging Associates